Vaqar M. Adhami

13.0k total citations · 1 hit paper
122 papers, 10.3k citations indexed

About

Vaqar M. Adhami is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Vaqar M. Adhami has authored 122 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 40 papers in Pathology and Forensic Medicine and 27 papers in Pharmacology. Recurrent topics in Vaqar M. Adhami's work include Tea Polyphenols and Effects (37 papers), Flavonoids in Medical Research (16 papers) and Cancer-related Molecular Pathways (15 papers). Vaqar M. Adhami is often cited by papers focused on Tea Polyphenols and Effects (37 papers), Flavonoids in Medical Research (16 papers) and Cancer-related Molecular Pathways (15 papers). Vaqar M. Adhami collaborates with scholars based in United States, India and Italy. Vaqar M. Adhami's co-authors include Hasan Mukhtar, Farrukh Afaq, Nihal Ahmad, Imtiaz A. Siddiqui, Deeba N. Syed, Naghma Khan, Mohammad Saleem, Sami Sarfaraz, Bilal Bin Hafeez and Eiman Mukhtar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Vaqar M. Adhami

121 papers receiving 10.0k citations

Hit Papers

Targeting Microtubules by... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vaqar M. Adhami United States 62 4.4k 2.0k 1.8k 1.7k 1.2k 122 10.3k
Naghma Khan United States 45 3.0k 0.7× 2.4k 1.2× 2.0k 1.2× 1.0k 0.6× 1.2k 1.0× 82 8.5k
Mou‐Tuan Huang United States 58 5.5k 1.3× 1.6k 0.8× 2.1k 1.2× 1.2k 0.7× 1.3k 1.0× 106 11.3k
Farrukh Afaq United States 68 4.6k 1.1× 1.9k 1.0× 3.0k 1.7× 2.1k 1.2× 1.9k 1.5× 125 12.4k
Chapla Agarwal United States 58 5.3k 1.2× 715 0.4× 1.2k 0.7× 1.3k 0.8× 1.1k 0.9× 178 9.4k
Santosh K. Katiyar United States 52 3.3k 0.8× 1.6k 0.8× 2.2k 1.2× 913 0.5× 626 0.5× 130 8.7k
Andreas J. Gescher United Kingdom 59 7.5k 1.7× 1.5k 0.7× 2.1k 1.2× 1.9k 1.1× 1.2k 1.0× 166 15.7k
Takuji Tanaka Japan 65 6.6k 1.5× 1.4k 0.7× 2.3k 1.3× 1.7k 1.0× 1.9k 1.5× 409 14.7k
Rajendra G. Mehta United States 49 5.6k 1.3× 1.8k 0.9× 1.9k 1.1× 969 0.6× 1.8k 1.5× 156 12.2k
Taeg Kyu Kwon South Korea 62 7.3k 1.7× 824 0.4× 874 0.5× 1.4k 0.8× 993 0.8× 398 13.4k
Imtiaz A. Siddiqui United States 50 2.6k 0.6× 1.3k 0.7× 1.0k 0.6× 676 0.4× 455 0.4× 88 6.2k

Countries citing papers authored by Vaqar M. Adhami

Since Specialization
Citations

This map shows the geographic impact of Vaqar M. Adhami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaqar M. Adhami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaqar M. Adhami more than expected).

Fields of papers citing papers by Vaqar M. Adhami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vaqar M. Adhami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaqar M. Adhami. The network helps show where Vaqar M. Adhami may publish in the future.

Co-authorship network of co-authors of Vaqar M. Adhami

This figure shows the co-authorship network connecting the top 25 collaborators of Vaqar M. Adhami. A scholar is included among the top collaborators of Vaqar M. Adhami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaqar M. Adhami. Vaqar M. Adhami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Mohammad Imran, Abid Hamid, Suvasmita Rath, et al.. (2018). AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer. Molecular Cancer Therapeutics. 18(2). 356–363. 13 indexed citations
2.
Younis, Tahira, Mohammad Imran Khan, Muhammad Rashid Khan, et al.. (2018). Nummularic acid, a triterpenoid, from the medicinal plant Fraxinus xanthoxyloides, induces energy crisis to suppress growth of prostate cancer cells. Molecular Carcinogenesis. 57(10). 1267–1277. 12 indexed citations
3.
Mukhtar, Eiman, Vaqar M. Adhami, Imtiaz A. Siddiqui, Ajit Kumar Verma, & Hasan Mukhtar. (2016). Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells. Molecular Cancer Therapeutics. 15(12). 2863–2874. 40 indexed citations
4.
Chamcheu, Jean Christopher, Vaqar M. Adhami, Stéphane Esnault, et al.. (2016). Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice. Antioxidants and Redox Signaling. 26(2). 49–69. 73 indexed citations
5.
Chamcheu, Jean Christopher, Harish C. Pal, Imtiaz A. Siddiqui, et al.. (2015). Prodifferentiation, Anti-Inflammatory and Antiproliferative Effects of Delphinidin, a Dietary Anthocyanidin, in a Full-Thickness Three-Dimensional Reconstituted Human Skin Model of Psoriasis. Skin Pharmacology and Physiology. 28(4). 177–188. 55 indexed citations
6.
Siddiqui, Imtiaz A., Dhruba J. Bharali, Minakshi Nihal, et al.. (2014). Excellent anti-proliferative and pro-apoptotic effects of (−)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine Nanotechnology Biology and Medicine. 10(8). 1619–1626. 119 indexed citations
7.
Siddiqui, Imtiaz A., Vanna Sanna, Vaqar M. Adhami, et al.. (2013). Prostate specific membrane antigen (PSMA) targeting nano-EGCG for prostate cancer prevention and treatment. Cancer Research. 1 indexed citations
8.
Bharali, Dhruba J., Imtiaz A. Siddiqui, Vaqar M. Adhami, et al.. (2011). Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects. Cancers. 3(4). 4024–4045. 78 indexed citations
10.
Prasad, Ananda S., Hasan Mukhtar, Frances W.J. Beck, et al.. (2010). Dietary Zinc and Prostate Cancer in the TRAMP Mouse Model. Journal of Medicinal Food. 13(1). 70–76. 33 indexed citations
11.
Tarapore, Rohinton S., Imtiaz A. Siddiqui, Mohammad Saleem, et al.. (2010). Specific targeting of Wnt/ -catenin signaling in human melanoma cells by a dietary triterpene lupeol. Carcinogenesis. 31(10). 1844–1853. 61 indexed citations
12.
Siddiqui, Imtiaz A., Vaqar M. Adhami, Dhruba J. Bharali, et al.. (2009). Introducing Nanochemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-Gallate. Cancer Research. 69(5). 1712–1716. 281 indexed citations
13.
Hafeez, Bilal Bin, Vaqar M. Adhami, Mohammad Asim, et al.. (2009). Targeted Knockdown of Notch1 Inhibits Invasion of Human Prostate Cancer Cells Concomitant with Inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen Activator. Clinical Cancer Research. 15(2). 452–459. 123 indexed citations
14.
Adhami, Vaqar M., Naghma Khan, & Hasan Mukhtar. (2009). Cancer Chemoprevention by Pomegranate: Laboratory and Clinical Evidence. Nutrition and Cancer. 61(6). 811–815. 127 indexed citations
15.
Adhami, Vaqar M. & Hasan Mukhtar. (2006). Polyphenols from green tea and pomegranate for prevention of prostate cancer. Free Radical Research. 40(10). 1095–1104. 79 indexed citations
16.
Mukhtar, Hasan, Mohammad Saleem, Farrukh Afaq, & Vaqar M. Adhami. (2004). Lupeol is a novel agent for skin cancer chemoprevention: Modulation of NFκB and Akt pathways.. Cancer Research. 64. 730–730. 1 indexed citations
17.
Saleem, Mohammad, Farrukh Afaq, Vaqar M. Adhami, & Hasan Mukhtar. (2004). Lupeol modulates NF-κB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene. 23(30). 5203–5214. 213 indexed citations
18.
Hussain, Tajamul, Sanjay Gupta, Vaqar M. Adhami, & Hasan Mukhtar. (2004). Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. International Journal of Cancer. 113(4). 660–669. 153 indexed citations
19.
Bhatia, Neehar, Vaqar M. Adhami, Imtiaz A. Siddiqui, & Hasan Mukhtar. (2003). Tea Beverage in Chemoprevention of Prostate Cancer. Nutrition and Cancer. 47(1).
20.
Adhami, Vaqar M., Farrukh Afaq, & Nihal Ahmad. (2001). Involvement of the Retinoblastoma (pRb)–E2F/DP Pathway during Antiproliferative Effects of Resveratrol in Human Epidermoid Carcinoma (A431) Cells. Biochemical and Biophysical Research Communications. 288(3). 579–585. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026